AVAH: Aveanna Healthcare Holdings Inc. - Summary | Jitta

Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

Price
$7.17
Loss Chance
44.3%
5.29JITTA SCORE
15.04%Under Jitta Line
Jitta Ranking
27 / 715
340 / 4,217
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (68)
Recent Business Performance (83)
Financial Strength (49)
Return to Shareholders (22)
Competitive Advantage (72)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning loss detected in 2023
Operating MarginInconsistent
Debt LevelVery High Long Term Debt
Key Stats
Jitta Score
Jitta Line
5.29
15.04%
3.06
209.62%
Health Care Services
6.32
16.84%
8.34
54.08%
6.50
43.95%
COMPANY DESCRIPTION
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.